LOS ANGELES - The United States Anti-Doping Agency alleges 100-meter world record-holder Tim Montgomery used five banned steroids and human growth hormone, the Los Angeles Times reported yesterday.
According to documents obtained by the newspaper, the USADA accuses Montgomery of using banned substances as far back as 2000, two years before setting the world record. In addition to the steroids and growth hormone, the agency says Montgomery used the blood-booster erythropoietin (EPO) and insulin.
In notifying Montgomery of alleged doping violations that might keep him off the US Olympic team this summer, the USADA also says it ``anticipates testimony'' - it didn't say from whom - regarding Montgomery's ``admitted use of the `clear,''' which later was determined to be the designer steroid tetrahydrogestrinone (THG).
Other evidence against Montgomery allegedly includes urine and blood test results the USADA says are consistent with the use of banned substances, calendars sketching out cycles of substance use, handwritten notes that make reference to various steroids, and laboratory payments, invoices and correspondence, the Times reported.
The accusations are contained in a letter the USADA sent to Montgomery June 7, notifying the sprinter of potential violations.
Montgomery responded to the letter last Friday, and a USADA review panel now will recommend whether to pursue charges against him.
Montgomery, the boyfriend of Marion Jones, who won five track medals at the Sydney Olympics, has never failed a doping test administered by track or Olympic authorities.
His attorney, Cristina Arguedas, said last week there is no evidence Montgomery has ever admitted using banned substances.
Arguedas also said that ``virtually all'' of the allegations against Montgomery come from the files of Victor Conte, founder of the Bay Area Laboratory Co-Operative (BALCO).
Montgomery and Conte had a ``bitter'' falling out and thus the ``very nature of Conte's relationship with Tim makes these documents suspect and unreliable on their face,'' Arguedas said.
Arguedas did not immediately respond to a telephone call from the Associated Press.
The review board is expected to meet this week to consider the cases of Montgomery and top US sprinters Chryste Gaines, Michelle Collins and Alvin Harrison.